Using peer support and rewards to reduce methamphetamine-related harm
Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM)
This study is looking at how friendly support from peers can help people using methamphetamine by offering rewards for reaching personal goals and connecting them with helpful resources, all aimed at making treatment easier and safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10590236 on NIH RePORTER |
What this research studies
This research investigates how peer recovery support specialists can help individuals using methamphetamine (MA) by providing harm reduction strategies and incentives. The study combines two effective approaches: contingency management, which rewards individuals for achieving personal harm reduction goals, and peer engagement, which connects users with supportive resources. By focusing on personalized goals, the research aims to improve treatment retention and reduce overdose risks among MA users. Participants will be engaged through a network of peer harm reduction organizations to implement these strategies effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use methamphetamine and are seeking harm reduction support or treatment.
Not a fit: Patients who do not use methamphetamine or are not interested in harm reduction strategies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose rates and improve the overall health and well-being of individuals using methamphetamine.
How similar studies have performed: Previous research has shown that combining peer support with contingency management can effectively improve treatment outcomes for substance use disorders.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Korthuis, Philip Todd — Oregon Health & Science University
- Study coordinator: Korthuis, Philip Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.